TAO Yuchen,LU Jiahui,DENG Jianqing,et al.Decision⁃making strategies of Lu Jiahui in treating primary immune thrombocytopenia with integrated traditional Chinese and western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):38-42.
TAO Yuchen,LU Jiahui,DENG Jianqing,et al.Decision⁃making strategies of Lu Jiahui in treating primary immune thrombocytopenia with integrated traditional Chinese and western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):38-42. DOI: 10.16305/j.1007-1334.2022.2203045.
Decision⁃making strategies of Lu Jiahui in treating primary immune thrombocytopenia with integrated traditional Chinese and western medicine
This paper sorts out the current treatment situation of primary immune thrombocytopenia (ITP), and according to the clinical reality, looks for the breakthrough point of ITP treatment in traditional Chinese medicine, and puts forward the decision-making ideas of ITP treatment in the integrative traditional Chinese and western medicine. Based on the standardized treatment of ITP in western medicine, combined with the accurate treatment based on syndrome differentiation of traditional Chinese medicine, the advantages are fostering strengths and avoiding weaknesses, even complementary. And two proven cases are presented.
关键词
原发免疫性血小板减少症特发性血小板减少性紫癜中西医结合治疗辨证论治临床经验
Keywords
primary immune thrombocytopeniaidiopathic thrombocytopenic purpuraintegrated Chinese and western medicine treatmenttreatment based on syndrome differentiationclinical experience
references
COOPER N, GHANIMA W. Immune thrombocytopenia[J]. N Engl J Med, 2019, 381(10): 945-955.
PROVAN D, ARNOLD D M, BUSSEL J B, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood Adv, 2019, 3(22): 3780-3817.
PROVAN D, SEMPLE J W. Recent advances in the mechanisms and treatment of immune thrombocytopenia[J]. Bio Medicine, 2022, 76: 103820.
YANG R, YAO H, LIN L, et al. Health-related quality of life and burden of fatigue in chinese patients with immune thrombocytopenia: a cross-sectional study[J]. Indian J Hematol Blood Transfus, 2020, 36(1): 104-111.
NEUNERT C, LIM W, CROWTHER M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood, 2011,117(16): 4190-4207.
ZITEK T, WEBER L, PINZON D, et al. Assessment and management of immune thrombocytopenia (ITP) in the emergency department: current perspectives[J]. Open Access Emerg Med, 2022, 14: 25-34.
ZHOU H, FAN J, HE J, et al. Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis[J]. Ann Hematol, 2022, 101(5): 953-961.
WONG R, SALEH M N, KHELIF A, et al. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study[J]. Blood, 2017, 130(23): 2527-2536.
LAMBERT M P, GERNSHEIMER T B. Clinical updates in adult immune thrombocytopenia[J]. Blood, 2017, 129(21): 2829-2835.
FREDERIKSEN H, MAEGBAEK M L, NORGAARD M. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study[J]. Br J Haematol, 2014, 166(2): 260-267.
GHANIMA W, GERNSHEIMER T, KUTER D J. How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment[J]. Blood, 2021, 137(20): 2736-2744.
KUBASCH A S, KISRO J, HESSLING J, et al. Disease management of patients with immune thrombocytopenia-results of a representative retrospective survey in Germany[J]. Ann Hematol, 2020, 99(9): 2085-2093.
VIANELLI N, AUTERI G, BUCCISANO F, et al. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives[J]. Ann Hematol, 2022, 101(5): 963-978.
NEWTON J L, REESE J A, WATSON S I, et al. Fatigue in adult patients with primary immune thrombocytopenia[J]. Eur J Haematol, 2011, 86(5): 420-429.
SHAW J, KILPATRICK K, EISEN M, et al. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States[J]. Platelets, 2020, 31(3): 307-314.
NEUNERT C, TERRELL D R, ARNOLD D M, et al. American society of hematology 2019 guidelines for immune thrombocytopenia[J]. Blood Adv, 2019, 3(23): 3829-3866.
Wang Yiqin’s clinical experience in treating hypertension
Cheng Yiqin’s experience in treating plasma cell mastitis
Professor Yan Xin’s clinical experience in using Guishao Liujun Decoction
Discussion on acupuncture treatment of impotence based on axis of “brain⁃heart⁃kidney⁃essence chamber”
Common syndrome characteristics and prescription textual research of kidney failing in storing will insomnia
Related Author
No data
Related Institution
School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine
Breast Surgery Department of Chinese Medicine,Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Institute of Traditional Chinese Medicine, Tongji University
Department of Andrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences
Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University; Zhang Xingping National Famous Chinese Medicine Expert Inheritance Studio